Provides with type 2 diabetes to attend an information session on Diabesity.
-the session is part of the cycle of itinerant informative workshops PronoKal ®-driven Group, to offer new solutions to patients with overweight and diabetes type 2
– according to the latest data published by the National Institute of statistics (INE), in Mataró more than 65,800 people suffer from overweight or obese and around 7,100 with diabetes
– the meeting held under the auspices of the Association of patients with diabetes of Maresme, which participated very actively in the dissemination of this meeting
Mataro, 2013 February.- provides fifteen attended Thursday 31 January, 6th Infoday on Diabesity, for type 2 diabetic patients, which took place at the Fundació Hospital de Mataró. The initiative is part of a series of informational meetings whose objective is to offer solutions and new tools for the treatment of the diabesity (obesity + type 2 diabetes). This sixth day has been sponsored by the Association of patients with diabetes of the Maresme and carried out with the collaboration of PronoKal ® Group, a firm specializing in the treatment of weight loss diet-based protein.
Dr. Marcelo E. Ninci, specialist in Endocrinology, was commissioned to provide for more than one hour talk Diabesity. New treatment of diabetic patient type 2 overweight: method Diaprokal ® ”, which was greatly valued by attendees. At the end of the activity, one of the issues most valued by attendees was the capacity offered by the method of enjoying results from the first day. Other relevant interests of the attendees was to know its index of Corporal mass (BMI) and the waist circumference, to discover the relationship between the increase in abdominal fat with increased insulin resistance.
One of the therapeutic innovations that offers the DiaproKal ® is having particularly into account the perimeter of waist of the patient, not only their excess weight, since abdominal fat is very active at the metabolic level and directly influences your type 2 diabetes ” said Dr. Ignacio SajouxMedical Adviser of PronoKal ®.
. from the hands of a local expert and like that in the rest of former days, its development is divided into three sections. First, is a review of the main figures of prevalence of obesity and diabetes in Spain. Here, the method is DiaproKal ®, a new specific treatment based on diet protein to patients with excess weight and DM2 or pre-diabetes and, finally, presents the results of the study DiaproKal ®, a clinical trial that evaluated the efficacy and safety of dietary protein vs. a diet low calorie in this type of patients.
Method DiaproKal ®
During the session, Dr. Ninci explained that the method DiaproKal ® has a protocol developed specifically for the treatment of the obese patient or with overweight and diabetes type 2 or pre-diabetes. This treatment intends to take the patient to a State of metabolic normalization where their weight, their waist circumference and its glycemic control figures are in normal parameters.
This new treatment was born in 2012, on the occasion of the good results obtained in the study DiaproKal ®, whose figures are established as one of the main issues of interest to attendees.
Thus, Dr. Ninci revealed that after 4 months of follow-up, the final results of the study are very important and a real alternative for the treatment of these patients, since they show that the protein diet (DiaproKal ®) is as safe as the Hipocalorica and more effective in the improvement of control Glycemic and established the weight loss in diabetic patients type 2 with obesity. Also, the decrease of the perimeter of waist (PC) achieved with dietary protein, it is more than double that with hypocaloric diet group, which emphasizes the interest of this data as a new therapeutic and key element in the improvement of these patients, given the relationship between intra-abdominal fat and insulin resistance.
The Diabesity in Mataro
In figures from the latest European health survey conducted by the National Statistical Institute in 2009, 14% of Catalans suffered obesity and 36% overweight, very similar numbers to the de Mataró (population between 100,000 and 400,000 inhabitants), in which more than 53% of the provides is overweightwhich means that more than 65,800 people suffer from obesity or overweight in the city. Note that being overweight is further accused in men than in women, since a 45,22% of men are overweight face a 30.23% of women. As for diabetes, according to data from the same study, it affects more than 7.100 provides.
About DiaproKal ®
method DiaproKal ® arrives to Spain at the hands of PronoKal ® Group, a firm based in Barcelona with offices in Barcelona, Madrid and Valencia, with a team consisting of more than 180 people. The method DiaproKal ® is a multidisciplinary treatment of weight loss and maintenance, for patients with diabetes type 2 or pre-diabetes, diet-based protein and under medical control.
DiaproKal ® has a multidisciplinary team that allows to approach the patient from all possible areas and a menu of flavors composed more than 30 products with different textures and flavors to make more bearable the active stages and metabolic stabilization. To this day, are already more than 500 physicians specifically trained for the prescription of this method and 20, dietitians-the nutritionists specializing in diabetes, giving support and advice to the patient during the whole process of weight loss and its lifestyle modification. In terms of physical activity, which is inescapably part of the method, DiaproKal ® has also a broad team of fixed collaborators specialized in the control and monitoring of physical activity in diabetic patients, as well as with experts in coaching, that accompany the patient throughout the process.
Both medical prescribers of DiaproKal ®, and the team of nutritionists-dietitians and physical activity and coaching consultants follow a program of updates on the method, the prescription of specific physical activity for diabetics, the management and monitoring of diabetic patients, in order to update and increase their knowledge about both pathologies. The safety and efficacy of the method has been analyzed through the clinical trial DiaproKal ®, whose results are being very positive and presented in the main scientific forums in the country.
To consult the medical prescriber’s method DiaproKal ® nearest, call 901-100-272.